Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Prednisolone in mHRPC
NCT00291005Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by Sanofi. Started Aug 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00291005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291005.